Susquehanna International Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$361M Sell
1,025,700
-389,100
-28% -$139M 0.04% 341
2025
Q4
$463M Buy
1,414,800
+264,700
+23% +$84M 0.05% 281
2025
Q3
$325M Sell
1,150,100
-369,800
-24% -$107M 0.04% 384
2025
Q2
$424M Sell
1,519,900
-171,900
-10% -$48.7M 0.06% 248
2025
Q1
$527M Buy
1,691,800
+658,100
+64% +$194M 0.09% 166
2024
Q4
$269M Sell
1,033,700
-409,900
-28% -$122M 0.04% 338
2024
Q3
$465M Sell
1,443,600
-271,900
-16% -$88.9M 0.08% 208
2024
Q2
$536M Sell
1,715,500
-10,600
-0.6% -$3.11M 0.1% 154
2024
Q1
$491M Buy
1,726,100
+469,900
+37% +$137M 0.09% 177
2023
Q4
$362M Sell
1,256,200
-334,100
-21% -$91M 0.07% 232
2023
Q3
$427M Buy
1,590,300
+228,700
+17% +$57.1M 0.09% 157
2023
Q2
$302M Sell
1,361,600
-225,300
-14% -$52.3M 0.06% 238
2023
Q1
$384M Buy
1,586,900
+191,800
+14% +$47.1M 0.08% 186
2022
Q4
$366M Buy
1,395,100
+135,000
+11% +$36.2M 0.09% 188
2022
Q3
$284M Sell
1,260,100
-253,700
-17% -$61.5M 0.07% 196
2022
Q2
$368M Buy
1,513,800
+89,800
+6% +$22M 0.09% 160
2022
Q1
$344M Sell
1,424,000
-428,900
-23% -$98.5M 0.06% 244
2021
Q4
$417M Buy
1,852,900
+288,900
+18% +$61M 0.06% 251
2021
Q3
$333M Sell
1,564,000
-492,900
-24% -$113M 0.04% 349
2021
Q2
$501M Buy
2,056,900
+274,600
+15% +$67.6M 0.07% 230
2021
Q1
$443M Buy
1,782,300
+512,900
+40% +$122M 0.07% 234
2020
Q4
$292M Sell
1,269,400
-146,600
-10% -$33.8M 0.05% 305
2020
Q3
$360M Sell
1,416,000
-81,100
-5% -$20.1M 0.07% 207
2020
Q2
$353M Sell
1,497,100
-342,900
-19% -$78.2M 0.09% 188
2020
Q1
$373M Buy
1,840,000
+335,000
+22% +$73.2M 0.12% 132
2019
Q4
$363M Buy
1,505,000
+248,900
+20% +$54.9M 0.1% 150
2019
Q3
$243M Sell
1,256,100
-271,100
-18% -$52M 0.08% 207
2019
Q2
$281M Sell
1,527,200
-433,300
-22% -$77.6M 0.1% 160
2019
Q1
$372M Buy
1,960,500
+783,900
+67% +$150M 0.15% 103
2018
Q4
$229M Sell
1,176,600
-159,400
-12% -$31.1M 0.09% 180
2018
Q3
$277M Buy
1,336,000
+63,900
+5% +$12.6M 0.09% 178
2018
Q2
$235M Sell
1,272,100
-399,200
-24% -$70.6M 0.08% 207
2018
Q1
$285M Buy
1,671,300
+335,300
+25% +$61.5M 0.1% 156
2017
Q4
$232M Sell
1,336,000
-115,400
-8% -$20.4M 0.08% 211
2017
Q3
$271M Sell
1,451,400
-327,700
-18% -$58.1M 0.1% 163
2017
Q2
$306M Buy
1,779,100
+140,000
+9% +$22.8M 0.13% 117
2017
Q1
$269M Sell
1,639,100
-618,100
-27% -$103M 0.14% 120
2016
Q4
$330M Buy
2,257,200
+65,000
+3% +$9.78M 0.17% 95
2016
Q3
$366M Sell
2,192,200
-28,900
-1% -$4.89M 0.18% 84
2016
Q2
$338M Buy
2,221,100
+409,400
+23% +$63.7M 0.18% 91
2016
Q1
$272M Buy
1,811,700
+293,900
+19% +$43.7M 0.14% 103
2015
Q4
$246M Sell
1,517,800
-168,600
-10% -$26.5M 0.11% 152
2015
Q3
$233M Buy
1,686,400
+214,500
+15% +$33.8M 0.1% 171
2015
Q2
$226M Sell
1,471,900
-58,200
-4% -$9.32M 0.1% 174
2015
Q1
$245M Sell
1,530,100
-398,100
-21% -$62.7M 0.11% 146
2014
Q4
$307M Buy
1,928,200
+640,200
+50% +$99.8M 0.12% 143
2014
Q3
$181M Buy
1,288,000
+281,800
+28% +$36.8M 0.07% 234
2014
Q2
$119M Sell
1,006,200
-137,700
-12% -$15.9M 0.05% 319
2014
Q1
$141M Buy
1,143,900
+12,200
+1% +$1.48M 0.07% 256
2013
Q4
$129M Sell
1,131,700
-118,200
-9% -$13.4M 0.06% 272
2013
Q3
$140M Buy
1,249,900
+339,500
+37% +$36.8M 0.07% 218
2013
Q2
$89.8M Buy
+910,400
New +$94.5M 0.05% 301

Other funds holding AMGN

Susquehanna International Group's AMGN Position: Q1 2026 in Review

Susquehanna International Group reduced its Amgen (AMGN) stake by 40% in Q1 2026, selling an estimated $75.3M and leaving 317,913 shares worth $112M. The position accounts for 0.01% of the portfolio, ranked #763.

Susquehanna International Group first reported a position in AMGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $173M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Susquehanna International Group held 317,913 shares of Amgen worth $112M as of Q1 2026.
  • Susquehanna International Group sold 211,258 Amgen shares in Q1 2026, an estimated $75.3M.
  • Amgen made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #763 holding.
  • Susquehanna International Group first reported a position in Amgen in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Amgen position peaked at $173M in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.